search
Back to results

Diagnostic Evaluation of Patients With Neuromuscular Disease

Primary Purpose

Neuromuscular Disease

Status
Completed
Phase
Locations
United States
Study Type
Observational
Intervention
Sponsored by
National Institute of Neurological Disorders and Stroke (NINDS)
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an observational trial for Neuromuscular Disease focused on measuring Myopathy, Dystrophy, Neuropathy, Muscle Weakness, Muscle Cramps and Pains, Neuromuscular Disorders

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

INCLUSION CRITERIA: Research patients will be studied under this protocol if they fulfill the following criteria: Have an identifiable neuromuscular disorder that may be suitable for a specific current or future protocol; Present a diagnostic puzzle in spite of the previously performed diagnostic work-up; Have unusual manifestation of a more usual neuromuscular disease; Have a disorder useful for teaching purposes. Patients should be referred by a physician who will continue their care after our evaluation. A report of the patients' visit and tests, along with suggestions or recommendations will be sent to each referring physician. There is a wide spectrum of neuromuscular diseases to be studied, among them are: peripheral neuropathies, myopathies, dystrophies, myasthenia, stiff person syndrome, muscle cramps, myotonias, motor neuron diseases, post-polio syndrome, and certain demyelinating disorders affecting both the central and the peripheral nervous system.

Sites / Locations

  • National Institutes of Health Clinical Center, 9000 Rockville Pike

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
April 19, 2001
Last Updated
June 30, 2017
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
search

1. Study Identification

Unique Protocol Identification Number
NCT00015470
Brief Title
Diagnostic Evaluation of Patients With Neuromuscular Disease
Official Title
Diagnostic Evaluation of Patients With Neuromuscular Diseases
Study Type
Observational

2. Study Status

Record Verification Date
May 10, 2007
Overall Recruitment Status
Completed
Study Start Date
April 16, 2001 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
May 10, 2007 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)

4. Oversight

5. Study Description

Brief Summary
The objectives of this protocol are to: 1) screen patients with various neuromuscular disorders and facilitate their entry into appropriate research protocols; 2) help resolve puzzling diagnostic neuromuscular problems and train fellows in the evaluation and treatment of Neuromuscular Diseases; and 3) provide follow up to patients who finished their participation in a previous study but they are not currently entered in another research protocol. No investigational treatments will be performed on this protocol but the tissues collected can be used for future research studies.
Detailed Description
The objectives of this protocol are to: 1) screen patients with various neuromuscular disorders and facilitate their entry into appropriate research protocols; 2) help resolve puzzling diagnostic neuromuscular problems and train fellows in the evaluation and treatment of Neuromuscular Diseases; and 3) provide follow up to patients who finished their participation in a previous study but they are not currently entered in another research protocol. No investigational treatments will be performed on this protocol but the tissues collected can be used for future research studies.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neuromuscular Disease
Keywords
Myopathy, Dystrophy, Neuropathy, Muscle Weakness, Muscle Cramps and Pains, Neuromuscular Disorders

7. Study Design

Enrollment
500 (false)

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
INCLUSION CRITERIA: Research patients will be studied under this protocol if they fulfill the following criteria: Have an identifiable neuromuscular disorder that may be suitable for a specific current or future protocol; Present a diagnostic puzzle in spite of the previously performed diagnostic work-up; Have unusual manifestation of a more usual neuromuscular disease; Have a disorder useful for teaching purposes. Patients should be referred by a physician who will continue their care after our evaluation. A report of the patients' visit and tests, along with suggestions or recommendations will be sent to each referring physician. There is a wide spectrum of neuromuscular diseases to be studied, among them are: peripheral neuropathies, myopathies, dystrophies, myasthenia, stiff person syndrome, muscle cramps, myotonias, motor neuron diseases, post-polio syndrome, and certain demyelinating disorders affecting both the central and the peripheral nervous system.
Facility Information:
Facility Name
National Institutes of Health Clinical Center, 9000 Rockville Pike
City
Bethesda
State/Province
Maryland
ZIP/Postal Code
20892
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Diagnostic Evaluation of Patients With Neuromuscular Disease

We'll reach out to this number within 24 hrs